Paxlovid Description

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

The information highlighted (if any) are the most recent updates for this brand.

Full Prescribing Info

Description

Each daily blister card contains 4 nirmatrelvir tablets and 2 ritonavir tablets.
Each pink nirmatrelvir film-coated tablet contains 150 mg of nirmatrelvir.
Each white ritonavir film-coated tablet contains 100 mg of ritonavir.
Excipients with known effect: Each nirmatrelvir 150 mg film-coated tablet contains 176 mg of lactose.
Excipients/Inactive Ingredients: Nirmatrelvir: Tablet core: Microcrystalline cellulose, Lactose monohydrate, Croscarmellose sodium, Colloidal silicon dioxide, Sodium stearyl fumarate.
Film-coat: Hypromellose (E464), Titanium dioxide (E171), Macrogol (E1521), Iron oxide red (E172).
Ritonavir: Tablet core: Copovidone, Sorbitan laurate, Colloidal anhydrous silica (E551), Anhydrous calcium hydrogen phosphate, Sodium stearyl fumarate.
Film-coat: Hypromellose (E464), Titanium dioxide (E171), Macrogol (E1521), Hydroxypropyl cellulose (E463), Talc (E553b), Colloidal anhydrous silica (E551), Polysorbate 80 (E433).

ritonavir

nirmatrelvir

Manufacturer:

Pfizer

Distributor:

Zuellig Pharma